Indian pharma cos eye weight-loss mkt

Indian drug-makers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions of Novo Nordisk's wildly in-demand Wegovy.

- 

With some analysts predicting a weight-loss market reaching $100 billion a year or more by the end of the decade, executives at Sun Pharma, Cipla, Dr Reddy's and Lupin some of the world's largest generic drugmakers-all said they have started work on Wegovy versions.